Apigenin for Sleep Quality

Research suggests that apigenin may support sleep quality through several biological mechanisms, including interactions with GABA receptors, anti-inflammatory pathways, and NAD+ preservation, with the available evidence coming from a 2024 narrative review, a 2026 preclinical mouse study, and a 2020 epidemiological study in Italian adults. The animal research indicates that apigenin, particularly when combined with magnesium, can significantly extend sleep duration and reduce neuroinflammatory markers, while the population-based study found that higher dietary apigenin intake was associated with better self-reported sleep quality, though this relationship appeared limited to normal-weight individuals. Studies indicate that human clinical findings have largely come from chamomile extract research rather than isolated apigenin supplementation, making it difficult to attribute effects to apigenin alone. Overall, the direction of evidence is consistently supportive, but the field is limited by a lack of controlled human trials using purified apigenin, meaning conclusions remain preliminary and further clinical research is needed before strong claims can be made.